A recent meta-analysis identified that P53 overexpression was associated with a two-fold risk of malignant transformation of OPMD [33], while CD44 is a well-established marker in many solid malignancies promoting tumour cell growth and migration [34]. Here, CD44 is linked to neoplasm.